- $119.04m
- $86.86m
- $30.73m
- 71
- 72
- 32
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.7 | 24.4 | 42.4 | 70 | 30.7 |
Cost of Revenue | |||||
Gross Profit | 18.8 | 15.9 | 33.8 | 60.5 | 21.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 18.5 | 25.4 | 21.8 | 23 | 25.3 |
Operating Profit | 8.19 | -0.978 | 20.6 | 47 | 5.42 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12.5 | 1.45 | 16.1 | 47.5 | 10.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.7 | 0.875 | 11.6 | 35.4 | 6.95 |
Net Income Before Extraordinary Items | |||||
Net Income | 8.7 | 0.875 | 11.6 | 35.4 | 6.95 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.7 | 0.875 | 11.6 | 35.4 | 6.95 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.285 | 0.077 | 0.477 | 1.5 | 0.353 |
Dividends per Share |